Key acquisition widens Pfizer's portfolio


Shutterstock photo

Pfizer ( PFE ), the world's largest pharmaceutical company, announced on Monday it is purchasing a consumer healthcare business.

The marquee products for Ferrosan, which is based in Copenhagen, include dietary supplements and lifestyle products. Pfizer, of New York, is expected to strengthen its dietary supplement portfolio by buying the line from Altor 2003 Fund GP.

"Ferrosan is an excellent strategic fit that strengthens our presence in dietary supplements with a new set of compelling brands and product pipeline," Paul Sturman, president of, Pfizer Consumer Healthcare, said in a statement. "The transaction will mark an important step towards expanding Ferrosan's brands through Pfizer's global footprint."

Based in the Nordic region, Ferrosan has been building a strong brand for consumer healthcare since 1920. Its serves Russia, Eastern Europe and Turkey, among other nations.

"We are very pleased that Ferrosan's innovative portfolio of leading brands will be joining Pfizer," Ferrosan president Ola Erici said in a statement. "We expect that, as part of the Pfizer portfolio, our products will build on their industry-leading positions and become available in more countries around the world. And, at the same time, Pfizer will be able to leverage its footprint in key Ferrosan markets with new Pfizer products."

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Personal Finance , Business

More from News

Subscribe News
Contributor: News

Market News
Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by